Pérez-Esparza Rodrigo, Oñate-Cadena Nelcy, Ramírez-Bermúdez Jesús, Espínola-Nadurille Mariana
Department of Neuropsychiatry, National Institute of Neurology and Neurosurgery.
Addiction Research Laboratory, National Institute of Neurology and Neurosurgery, Mexico City, Mexico.
Neurologist. 2018 Mar;23(2):51-52. doi: 10.1097/NRL.0000000000000166.
Hyperammonemic encephalopathy secondary to the use of valproate is rare without evidence of hepatotoxicity, and it usually presents with confusion, agitation, irritability, cognitive disturbances, lethargy, coma, and death. We present the case of a 21-year-old woman presenting with catatonia as a manifestation of hyperammonemic encephalopathy that resolved with the normalization of ammonia and suspension of valproate.
在没有肝毒性证据的情况下,使用丙戊酸盐继发的高氨血症性脑病很罕见,其通常表现为意识模糊、躁动、易怒、认知障碍、嗜睡、昏迷及死亡。我们报告一例21岁女性病例,该患者以紧张症为高氨血症性脑病的一种表现形式,随着氨水平恢复正常及停用丙戊酸盐,症状得以缓解。